Conference Banner

International Conference on Cancer Research & Immuno-Oncology

International Conference on Cancer Research & Immuno-Oncology

📍

Dubai, UAE

📅

April 3,4,5 2025

“Innovating Immunity: Transforming Cancer Research into Life-Saving Therapies”

Conference Overview

"The International Conference on Cancer Research & Immuno-Oncology brings together leading scientists, clinicians, researchers, academicians, and healthcare professionals from across the globe to explore the latest advancements in cancer biology and immunotherapy. This dynamic forum aims to foster collaboration, promote knowledge exchange, and accelerate the translation of groundbreaking research into effective clinical applications. The conference will highlight emerging trends, innovative technologies, and transformative therapeutic strategies shaping the future of oncology. The program will feature keynote presentations, plenary sessions, panel discussions, and oral and poster presentations covering a wide spectrum of topics including tumor immunology, precision oncology, cancer genomics, targeted therapies, CAR-T cell therapy, immune checkpoint inhibitors, biomarker discovery, and translational research. Participants will gain valuable insights into cutting- edge discoveries while engaging in meaningful discussions with global experts and industry leaders. Designed to encourage interdisciplinary collaboration, this conference provides an exceptional platform for networking, partnership building, and professional development. By uniting research, clinical expertise, and innovation, the event aims to contribute to improved patient outcomes and to advance the global fight against cancer through the power of immuno-oncology."

Renowned international keynote and plenary speakers in oncology and immunotherapy
Latest breakthroughs in cancer biology and tumor microenvironment research
Advances in immuno-oncology, including CAR-T cell therapy and immune checkpoint inhibitors
Precision oncology and biomarker-driven treatment strategies
Translational research bridging laboratory discoveries to clinical applications
Innovative targeted therapies and combination treatment approaches
Clinical trial updates and real-world evidence in cancer care
Emerging technologies in cancer diagnostics and genomics
Young researcher forum and student presentation sessions
Poster presentations showcasing cutting-edge research findings

Conference Information

Dates

April 3,4,5 2025

3-day program

Venue

Dubai, UAE

Featured Keynote Speakers

Rajvir Dahiya

University of California San Francisco, United States

Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Rajvir Dahiya holds Ph.D. in Experimental Medicine from Post Graduate Institute of Medical Education and Research Chandigarh, India, post-doctoral fellowship in medical oncology research from the University of Chicago Pritzker School of Medicine, M.D. from the Kagoshima University Faculty of Medicine, Kagoshima, Japan and D.Sc. from the Osaka University Graduate School of Medicine, Osaka, Japan. He became director of Oncology Urology Oncology Research Center at the UCSF/VAMC in 1991. After 34 years of service, he retired as a Professor Emeritus and Director of Urology Research Center. Dahiya has published more than 550 original research manuscripts. Dahiya’s world ranking in medicine is 4759 and USA ranking is 2644 with more than 35,500 research citations and D-index of 107 in 2024. He has written books and holds multiple patents in oncology. Based on the NIH and VA data base NIH Reporter and Grantome, Dahiyas research programs were supported (99 times awarded) by the NIH and VA. Currently, he is an associate editor of “Clinical Cancer Research” journal.

Svetlana Baziliansky

University of Haifa, Israel

Svetlana Baziliansky

Svetlana Baziliansky

University of Haifa, Israel

Dr. Svetlana Baziliansky is a researcher and lecturer specializing in emotion regulation, self- compassion, personal resilience, psychological distress, quality of life, fatigue, and end- of-life care. She previously worked for over 16 years as a senior oncology social worker, an experience that deeply shaped her research interests and clinical perspective. Currently, she is based at the School of Social Work, University of Haifa, where her work focuses on the psychosocial aspects of cancer survivorship and palliative care, aiming to enhance patients’ well-being and adaptive coping. Dr. Baziliansky has presented her research at national and international conferences and continues to integrate research with clinical insights.

Eleni Petsalaki

University of Crete, Greece

Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece

Dr Eleni Petsalaki is a Post Doctoral Research Scientist at University of Crete, Greece. She completed her PhD in 2014 in Molecular Biology and Biomedicine at the Department of Biology. Her main interests are mitotic cell division and mechanisms that monitor mitotic progression called the mitotic spindle checkpoint and the abscission checkpoint. She is an author of 17 publications including Journal of Cell Biology, Nature Communications, Journal of Cell Science and others. Her publications have received >600 citations so far. She is currently a member of FEBS, AACR, EACR and Royal Society of Biology.

Michael Thompson

University of Toronto, Canada

Michael Thompson

Michael Thompson

University of Toronto, Canada

Professor Michael Thompson was appointed Lecturer in Instrumental Analysis at Loughborough University in 1971. He then moved to the University of Toronto where he is now Professor of Bioanalytical Chemistry. He is recognized internationally for his pioneering work over many years in the area of research into new biosensor technologies. His research is centered on the surface chemistry of proteins, cells and bacteria. He has been awarded many prestigious international prizes for his research including The Robert Boyle Gold Medal of the Royal Society of Chemistry, The Elsevier Prize in Biosensor and Bioelectronics Technology, the E.W.R. Steacie Award of the Chemical Society of Canada, and recently the 2023 Royal Society of Chemistry Horizons Prize in Analytical Science.

Participant Profile Analysis

62%
Clinical Practitioners

General practitioners, specialists in prosthodontics, endodontics, orthodontics, and implant dentistry

28%
Academic Researchers

University faculty, postdoctoral researchers, PhD candidates, and postgraduate residents

10%
Industry Professionals

Technology company representatives, dental laboratory technicians, biomedical engineers

Geographic Distribution

38%
Europe
27%
Asia-Pacific
22%
North America
13%
Other Regions

Explore Other Past Conference Editions

Review proceedings and outcomes from previous years of the conference series

Watsapp